Webinar: Thursday, 13 February 2025, 7PM

Multiple myeloma and the role of lenalidomide

Join Medical Chronicle for a free, one-hour, CPD-accredited webinar on Multiple myeloma and the role of lenalidomide. This webinar is sponsored by Adcock and presented by Dr David Brittain.

Presented by
Conrad Strydom

Conrad Strydom

  • Editor: Medical Academic
Dr David Brittain

Dr David Brittain

  • Clinical Haematologist
Dr David Brittain graduated his MB ChB in 1988 from the University of the Witwatersrand. He specialised in Haematopathology (1996) and super specialised in Clinical Haematology (1998) from the same university. After running his own private practice in Johannesburg from 2000 - 2008 he joined the Alberts, Bouwer & Jordaan practice where he has worked as a Director in the Haematology and Cellular Therapy field. He has a special interest in treating Leukaemia, Lymphoma, Myeloma, Stem Cell Transplantation and CAR-T Therapy. He is a Member of the South African Society of Clinical Haematology (SACHaS), the American Society of Haematology (ASH), Chairman of BloodSA, Chairman of the BloodSA Multiple Myeloma Working Group, member of BloodSA Cell and Gene Therapy Working Party and serves on the Executive Committee of the South African Stem Cell Transplant Society (SASCeTS). He also is an Honorary Senior Lecturer in the division of Clinical Haematology at the University of Cape Town. In his spare time, he cycles, runs and rows.

1,546 professionals have already registered.

Days
:
Hours
:
Minutes
:
Seconds

Webinar Registration

By registering for this webinar, you agree to our Terms & Conditions.

New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.

Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.

Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.